NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000052151

Registered date:08/09/2023

Construction of data for implementation of comprehensive cancer genome profiling using genome-guided system

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedSolid cancer
Date of first enrollment2023/08/01
Target sample size200
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeRate of patients for whom genome-guided treatment could be proposed among patients who underwent cancer gene panel testing at St. Marianna University Hospital and were analysed using the MH Guide for annotation based on measured data.
Secondary Outcomedruggable genomic alterations *Definition in the St. Marianna University Hospital Expert Panel: genomic alterations with evidence level C1 or higher or evidence level D2 and promising investigational drugs in the Guidance for cancer treatment based on gene panel testing using next-generation sequencers. *Definition in the MH Guide: genomic alterations with a Biomarker score of 4 or more. Time spent on annotation.

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaCases judged by the principal investigator to be inappropriate for participation in the study

Related Information

Contact

public contact
Name Kiyomi Imoto
Address 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa Japan 216-8511
Telephone 0449778111
E-mail imoto@marianna-u.ac.jp
Affiliation St. Marianna University Hospital Centre for the Genomic Medicine
scientific contact
Name Yu Sunakawa
Address 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa Japan
Telephone 0449778111
E-mail y.sunakawa@marianna-u.ac.jp
Affiliation St. Marianna University School of Medicine Department of Clinical Oncology